RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,338,000 | +61.8% | 1,184,700 | +278.6% | 0.02% | +100.0% |
| Q4 2021 | $827,000 | -15.6% | 312,900 | +15.9% | 0.01% | -25.0% |
| Q3 2021 | $980,000 | -49.3% | 270,000 | -39.3% | 0.01% | -53.8% |
| Q2 2021 | $1,932,000 | +1023.3% | 445,000 | +790.0% | 0.03% | +550.0% |
| Q1 2021 | $172,000 | – | 50,000 | +24900.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 200 | -99.9% | 0.00% | -100.0% |
| Q3 2020 | $336,000 | +166.7% | 140,000 | +154.5% | 0.01% | -20.0% |
| Q4 2018 | $126,000 | – | 55,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,020,719 | $3,746,000 | 2.58% |
| Boxer Capital, LLC | 1,351,137 | $4,959,000 | 2.22% |
| Palo Alto Investors LP | 5,186,088 | $19,033,000 | 1.11% |
| DAFNA Capital Management LLC | 340,000 | $1,248,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 907,203 | $3,329,435,000 | 0.86% |
| Rhenman & Partners Asset Management AB | 1,400,000 | $5,138,000,000 | 0.82% |
| NEA Management Company, LLC | 3,243,150 | $11,902,000 | 0.53% |
| Cormorant Asset Management, LP | 1,155,600 | $4,241,000 | 0.47% |
| Ghost Tree Capital, LLC | 700,000 | $2,569,000 | 0.42% |
| Rock Springs Capital Management LP | 1,810,000 | $6,643,000 | 0.42% |